A citation-based method for searching scientific literature

Xinmin Xie, Amy L Van Deusen, Iuliia Vitko, Daniella A Babu, Lucinda A Davies, Nhung Huynh, Holden Cheng, Naibo Yang, Paula Q Barrett, Edward Perez-Reyes. Assay Drug Dev Technol 2007
Times Cited: 39







List of co-cited articles
365 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels.
Zhi-Qiang Yang, James C Barrow, William D Shipe, Kelly-Ann S Schlegel, Youheng Shu, F Vivien Yang, Craig W Lindsley, Kenneth E Rittle, Mark G Bock, George D Hartman,[...]. J Med Chem 2008
74
28

Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca2+ channel antagonist.
William D Shipe, James C Barrow, Zhi-Qiang Yang, Craig W Lindsley, F Vivien Yang, Kelly-Ann S Schlegel, Youheng Shu, Kenneth E Rittle, Mark G Bock, George D Hartman,[...]. J Med Chem 2008
99
25

Nomenclature of voltage-gated calcium channels.
E A Ertel, K P Campbell, M M Harpold, F Hofmann, Y Mori, E Perez-Reyes, A Schwartz, T P Snutch, T Tanabe, L Birnbaumer,[...]. Neuron 2000
686
23

A high-throughput assay for evaluating state dependence and subtype selectivity of Cav2 calcium channel inhibitors.
Ge Dai, Rodolfo J Haedo, Vivien A Warren, Kevin S Ratliff, Randal M Bugianesi, Alison Rush, Mark E Williams, James Herrington, McHardy M Smith, Owen B McManus,[...]. Assay Drug Dev Technol 2008
49
23

Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception.
Emmanuel Bourinet, Abdelkrim Alloui, Arnaud Monteil, Christian Barrère, Brigitte Couette, Olivier Poirot, Anne Pages, John McRory, Terrance P Snutch, Alain Eschalier,[...]. EMBO J 2005
320
20


T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures.
Elizabeth Tringham, Kim L Powell, Stuart M Cain, Kristy Kuplast, Janette Mezeyova, Manjula Weerapura, Cyrus Eduljee, Xinpo Jiang, Paula Smith, Jerrie-Lynn Morrison,[...]. Sci Transl Med 2012
115
20

A fluorescence-based high-throughput screening assay for the identification of T-type calcium channel blockers.
Francesco Belardetti, Elizabeth Tringham, Cyrus Eduljee, Xinpo Jiang, Haiheng Dong, Adam Hendricson, Yoko Shimizu, Diana L Janke, David Parker, Janette Mezeyova,[...]. Assay Drug Dev Technol 2009
20
40

Pharmacological characterization of recombinant N-type calcium channel (Cav2.2) mediated calcium mobilization using FLIPR.
Elfrida R Benjamin, Farhana Pruthi, Shakira Olanrewaju, Shen Shan, Denise Hanway, Xuesong Liu, Rok Cerne, Daniel Lavery, Kenneth J Valenzano, Richard M Woodward,[...]. Biochem Pharmacol 2006
21
33

A nonadherent cell-based HTS assay for N-type calcium channel using calcium 3 dye.
Mary Lou Lubin, Tasha L Reitz, Matthew J Todd, Christopher M Flores, Ning Qin, Hong Xin. Assay Drug Dev Technol 2006
18
38


T-type Ca2+ channels as therapeutic targets in the nervous system.
Hee-Sup Shin, Eun-Ji Cheong, Soonwook Choi, Jungryun Lee, Heung Sik Na. Curr Opin Pharmacol 2008
66
17

Population patch clamp improves data consistency and success rates in the measurement of ionic currents.
Alan Finkel, Andrew Wittel, Naibo Yang, Shawn Handran, Jan Hughes, James Costantin. J Biomol Screen 2006
95
17

Structure and regulation of voltage-gated Ca2+ channels.
W A Catterall. Annu Rev Cell Dev Biol 2000
17

Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels.
E M Talley, L L Cribbs, J H Lee, A Daud, E Perez-Reyes, D A Bayliss. J Neurosci 1999
593
17

Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve.
Miljen M Jagodic, Sriyani Pathirathna, Pavle M Joksovic, WooYong Lee, Michael T Nelson, Ajit K Naik, Peihan Su, Vesna Jevtovic-Todorovic, Slobodan M Todorovic. J Neurophysiol 2008
152
17

International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels.
William A Catterall, Edward Perez-Reyes, Terrance P Snutch, Joerg Striessnig. Pharmacol Rev 2005
853
17

Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants.
Sarah E Heron, Houman Khosravani, Diego Varela, Chris Bladen, Tristiana C Williams, Michelle R Newman, Ingrid E Scheffer, Samuel F Berkovic, John C Mulley, Gerald W Zamponi. Ann Neurol 2007
129
17

Automated tight seal electrophysiology for assessing the potential hERG liability of pharmaceutical compounds.
Huimin Tao, David Santa Ana, António Guia, Mingxian Huang, Joseph Ligutti, George Walker, Khachonesine Sithiphong, Florence Chan, Tao Guoliang, Zoya Zozulya,[...]. Assay Drug Dev Technol 2004
66
15

Ionworks HT: a new high-throughput electrophysiology measurement platform.
Kirk Schroeder, Brad Neagle, Derek J Trezise, Jennings Worley. J Biomol Screen 2003
175
15

High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology.
John Dunlop, Mark Bowlby, Ravikumar Peri, Dmytro Vasilyev, Robert Arias. Nat Rev Drug Discov 2008
321
15

Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels.
S Choi, H S Na, J Kim, J Lee, S Lee, D Kim, J Park, C-C Chen, K P Campbell, H-S Shin. Genes Brain Behav 2007
160
15


Effects of T-type calcium channel blockers on a parkinsonian tremor model in rats.
Hideto Miwa, Jinsoo Koh, Yoshinori Kajimoto, Tomoyoshi Kondo. Pharmacol Biochem Behav 2011
33
18

Voltage-gated calcium channels.
William A Catterall. Cold Spring Harb Perspect Biol 2011
796
15

Role of voltage-gated calcium channels in epilepsy.
Gerald W Zamponi, Philippe Lory, Edward Perez-Reyes. Pflugers Arch 2010
118
15

State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects.
Amaury Francois, Nicolas Kerckhove, Mathieu Meleine, Abdelkrim Alloui, Christian Barrere, Agathe Gelot, Victor N Uebele, John J Renger, Alain Eschalier, Denis Ardid,[...]. Pain 2013
71
15

Randomized controlled study of the T-type calcium channel antagonist MK-8998 for the treatment of acute psychosis in patients with schizophrenia.
Michael F Egan, Xin Zhao, Andrew Smith, Matthew D Troyer, Victor N Uebele, Valerii Pidkorytov, Kevin Cox, Michael Murphy, Duane Snavely, Christopher Lines,[...]. Hum Psychopharmacol 2013
27
22

Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2+ channel.
H Saegusa, T Kurihara, S Zong, A Kazuno , Y Matsuda, T Nonaka, W Han, H Toriyama, T Tanabe. EMBO J 2001
243
12

State-dependent inhibition of L-type calcium channels: cell-based assay in high-throughput format.
Menghang Xia, John P Imredy, Ken S Koblan, Paul Bennett, Thomas M Connolly. Anal Biochem 2004
28
17

The role of T-channels in the generation of thalamocortical rhythms.
Diego Contreras. CNS Neurol Disord Drug Targets 2006
49
12


Characterization of a hERG screen using the IonWorks HT: comparison to a hERG rubidium efflux screen.
Steve Sorota, Xue-Song Zhang, Michael Margulis, Kristal Tucker, Tony Priestley. Assay Drug Dev Technol 2005
61
12

Reversal of experimental neuropathic pain by T-type calcium channel blockers.
Ahmet Dogrul, Luis R Gardell, Michael H Ossipov, F Cankat Tulunay, Josephine Lai, Frank Porreca. Pain 2003
159
12

Mibefradil block of cloned T-type calcium channels.
R L Martin, J H Lee, L L Cribbs, E Perez-Reyes, D A Hanck. J Pharmacol Exp Ther 2000
185
12

Cellular HTS assays for pharmacological characterization of Na(V)1.7 modulators.
Shephali Trivedi, Kim Dekermendjian, Ronald Julien, Jian Huang, Per-Eric Lund, Johannes Krupp, Robert Kronqvist, Olof Larsson, Robert Bostwick. Assay Drug Dev Technol 2008
40
12

QPatch: the missing link between HTS and ion channel drug discovery.
Chris Mathes, Søren Friis, Michael Finley, Yi Liu. Comb Chem High Throughput Screen 2009
44
12

Sodium channel inhibitor drug discovery using automated high throughput electrophysiology platforms.
Neil Castle, David Printzenhoff, Shannon Zellmer, Brett Antonio, Alan Wickenden, Christopher Silvia. Comb Chem High Throughput Screen 2009
48
12

Voltage-gated calcium channels and idiopathic generalized epilepsies.
Houman Khosravani, Gerald W Zamponi. Physiol Rev 2006
128
12

Antagonism of T-type calcium channels inhibits high-fat diet-induced weight gain in mice.
Victor N Uebele, Anthony L Gotter, Cindy E Nuss, Richard L Kraus, Scott M Doran, Susan L Garson, Duane R Reiss, Yuxing Li, James C Barrow, Thomas S Reger,[...]. J Clin Invest 2009
59
12

TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent.
Wonjoo Choe, Richard B Messinger, Emily Leach, Veit-Simon Eckle, Aleksandar Obradovic, Reza Salajegheh, Vesna Jevtovic-Todorovic, Slobodan M Todorovic. Mol Pharmacol 2011
112
12

T-type calcium channels inhibitors: a patent review.
Fabrizio Giordanetto, Laurent Knerr, Andreas Wållberg. Expert Opin Ther Pat 2011
35
14

In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
Richard L Kraus, Yuxing Li, Yun Gregan, Anthony L Gotter, Victor N Uebele, Steven V Fox, Scott M Doran, James C Barrow, Zhi-Qiang Yang, Thomas S Reger,[...]. J Pharmacol Exp Ther 2010
80
12

The Discovery and Characterization of ML218: A Novel, Centrally Active T-Type Calcium Channel Inhibitor with Robust Effects in STN Neurons and in a Rodent Model of Parkinson's Disease.
Zixiu Xiang, Analisa D Thompson, John T Brogan, Michael L Schulte, Bruce J Melancon, Debbie Mi, L Michelle Lewis, Bende Zou, Liya Yang, Ryan Morrison,[...]. ACS Chem Neurosci 2011
57
12

Positive allosteric interaction of structurally diverse T-type calcium channel antagonists.
Victor N Uebele, Cindy E Nuss, Steven V Fox, Susan L Garson, Razvan Cristescu, Scott M Doran, Richard L Kraus, Vincent P Santarelli, Yuxing Li, James C Barrow,[...]. Cell Biochem Biophys 2009
41
12

T-type calcium channel as a new therapeutic target for tremor.
Hideto Miwa, Tomoyoshi Kondo. Cerebellum 2011
29
17

T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of rats.
Jason M Uslaner, Sean M Smith, Sarah L Huszar, Rashida Pachmerhiwala, Richard M Hinchliffe, Joshua D Vardigan, Shannon J Nguyen, Nathan O Surles, Lihang Yao, James C Barrow,[...]. Neuropharmacology 2012
28
17

Characterization of the substituted N-triazole oxindole TROX-1, a small-molecule, state-dependent inhibitor of Ca(V)2 calcium channels.
Andrew M Swensen, James Herrington, Randal M Bugianesi, Ge Dai, Rodolfo J Haedo, Kevin S Ratliff, McHardy M Smith, Vivien A Warren, Stephen P Arneric, Cyrus Eduljee,[...]. Mol Pharmacol 2012
36
13

Mechanisms by which a CACNA1H mutation in epilepsy patients increases seizure susceptibility.
Veit-Simon Eckle, Aleksandr Shcheglovitov, Iuliia Vitko, Deblina Dey, Chan Choo Yap, Bettina Winckler, Edward Perez-Reyes. J Physiol 2014
54
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.